Medpace Holdings Inc has a consensus price target of $408, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from Guggenheim, Baird, and Jefferies on April 24, 2024, April 24, 2024, and April 23, 2024. With an average price target of $456 between Guggenheim, Baird, and Jefferies, there's an implied 16.99% upside for Medpace Holdings Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/24/2024 | MEDP | Buy Now | Medpace Hldgs | $389.77 | 19.04% | Guggenheim | Sandy Draper | $453 → $464 | Maintains | Buy | Get Alert |
04/24/2024 | MEDP | Buy Now | Medpace Hldgs | $389.77 | 16.48% | Baird | Eric Coldwell | $446 → $454 | Maintains | Outperform | Get Alert |
04/23/2024 | MEDP | Buy Now | Medpace Hldgs | $389.77 | 15.45% | Jefferies | David Windley | $340 → $450 | Upgrade | Hold → Buy | Get Alert |
03/18/2024 | MEDP | Buy Now | Medpace Hldgs | $389.77 | 1.34% | Deutsche Bank | Justin Bowers | → $395 | Initiates | → Hold | Get Alert |
03/08/2024 | MEDP | Buy Now | Medpace Hldgs | $389.77 | 23.15% | UBS | John Sourbeer | $452 → $480 | Maintains | Buy | Get Alert |
02/15/2024 | MEDP | Buy Now | Medpace Hldgs | $389.77 | 15.97% | UBS | John Sourbeer | $282 → $452 | Upgrade | Neutral → Buy | Get Alert |
02/14/2024 | MEDP | Buy Now | Medpace Hldgs | $389.77 | 4.68% | Baird | Eric Coldwell | $312 → $408 | Maintains | Outperform | Get Alert |
01/17/2024 | MEDP | Buy Now | Medpace Hldgs | $389.77 | -19.95% | Baird | Eric Coldwell | $302 → $312 | Maintains | Outperform | Get Alert |
10/24/2023 | MEDP | Buy Now | Medpace Hldgs | $389.77 | -25.85% | Baird | Eric Coldwell | $270 → $289 | Upgrade | Neutral → Outperform | Get Alert |
07/25/2023 | MEDP | Buy Now | Medpace Hldgs | $389.77 | -29.96% | Guggenheim | Sandy Draper | $252 → $273 | Maintains | Buy | Get Alert |
05/08/2023 | MEDP | Buy Now | Medpace Hldgs | $389.77 | -35.35% | Guggenheim | Sandy Draper | → $252 | Upgrade | Neutral → Buy | Get Alert |
02/15/2023 | MEDP | Buy Now | Medpace Hldgs | $389.77 | -40.22% | Baird | Eric Coldwell | $226 → $233 | Maintains | Neutral | Get Alert |
10/27/2022 | MEDP | Buy Now | Medpace Hldgs | $389.77 | — | UBS | John Sourbeer | — | Upgrade | Sell → Neutral | Get Alert |
10/26/2022 | MEDP | Buy Now | Medpace Hldgs | $389.77 | -44.33% | Baird | Eric Coldwell | $200 → $217 | Maintains | Neutral | Get Alert |
09/07/2022 | MEDP | Buy Now | Medpace Hldgs | $389.77 | -63.57% | UBS | John Sourbeer | → $142 | Initiates | → Sell | Get Alert |
05/24/2022 | MEDP | Buy Now | Medpace Hldgs | $389.77 | — | Guggenheim | Sandy Draper | — | Initiates | → Neutral | Get Alert |
07/20/2021 | MEDP | Buy Now | Medpace Hldgs | $389.77 | -47.4% | Credit Suisse | Erin Wilson | — | Maintains | Outperform | Get Alert |
The latest price target for Medpace Hldgs (NASDAQ: MEDP) was reported by Guggenheim on April 24, 2024. The analyst firm set a price target for $464.00 expecting MEDP to rise to within 12 months (a possible 19.04% upside). 11 analyst firms have reported ratings in the last year.
The latest analyst rating for Medpace Hldgs (NASDAQ: MEDP) was provided by Guggenheim, and Medpace Hldgs maintained their buy rating.
The last upgrade for Medpace Holdings Inc happened on April 23, 2024 when Jefferies raised their price target to $450. Jefferies previously had a hold for Medpace Holdings Inc.
There is no last downgrade for Medpace Hldgs.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medpace Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medpace Hldgs was filed on April 24, 2024 so you should expect the next rating to be made available sometime around April 24, 2025.
While ratings are subjective and will change, the latest Medpace Hldgs (MEDP) rating was a maintained with a price target of $453.00 to $464.00. The current price Medpace Hldgs (MEDP) is trading at is $389.77, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.